Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 03, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. to Present at the 2021 LD Micro Invitational XI

WIXOM, Mich., June 03, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
May 17, 2021 16:05 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Provides First Quarter 2021 Financial and Operational Update

-Home Infusion FPC Program expected to initiate Phase 2 trial in second half of 2021- -Company received marketing approval in Canada for Triferic AVNU™- -Conference call and webcast on...
May 03, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. to Report First Quarter 2021 Financial and Operating Results on May 17, 2021

WIXOM, Mich., May 03, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and...
April 27, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Marketing Approval of Triferic® AVNU™ in Canada

WIXOM, Mich., April 27, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
April 22, 2021 16:05 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Presents Data on Diagnosis and Management of Iron Deficiency Anemia in Home Parenteral Nutrition Patients at the NHIA 2021 Annual Conference

WIXOM, Mich., April 22, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
March 31, 2021 16:05 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. Provides Fourth Quarter and Full Year 2020 Financial and Operational Update

- 2020 revenue of $62.2 million - - Ended the year with $58.7 million in cash, cash equivalents and investments - - Conference call and webcast on Wednesday, March 31st at 4:30 p.m. ET - WIXOM,...
March 18, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. to Report Fourth Quarter and Full Year 2020 Financial and Operating Results on March 31, 2021

WIXOM, Mich., March 18, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
March 04, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

WIXOM, Mich., March 04, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
February 09, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis

WIXOM, Mich., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management...
February 01, 2021 07:00 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd.

WIXOM, Mich., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right